View drug registration information details.


ItemsRegistration information
ID164
No164
Brand NameFLEMING 625 MG
IngredientsAMOXICILLIN TRIHYDRATE 575 MG EQ TO AMOXICILLIN 500 MG, DILUTED POTASSIUM CLAVULANATE 126.250 MG EQ TO CLAVULANIC ACID 125 MG
Dosage FormFILM-COATED TABLETS
Primary PackagingBLISTERPACK
StorageSTORE BELOW 30 C
Shelf Life2 YEARS
Pack SizeBOX OF 1 X 10'S
Dispensing CategoryPrescription only
ATC ClassificationJO1CR02
Pharmaceutical ClassANTIBACTERIAL COMBINATIONS
IndicationsFOR SHORT TERM TREATMENT OF BACTERIAL INFECTION AT THE FOLLOWING SITE: LOWER AND UPPER RESPIRATORY TRACT INFECTION, GENITO-URINARY TRACT AND ABDOMINAL INFECTION, SKIN AND SOFT TISSUE INFECTION, DENTAL INFECTION, BONE AND JOINT INFECTIONS
ContraindicationsATTENTION SHOULD BE PAID TO POSSIBLE CROSS -SENSITIVITY WITH OTHER BETA LACTAM ANTIBIOTICS,E.G.CEPHALOSPORINE, A PREVIOUS HISTORY OF CO-AMOXICLAV OR PENICILLIN-ASSOCIATED JAUNDICE /HEPATIC DYSFUNCTION
Side EffectsSIDE EFFECTS, AS WITH AMOXICILLIN, ARE UNCOMMON AND MAINLY OF AMILD AND TRANSITORY NATURE,GASTROINTESTINAL REACTIONS EFFECTS INCLUDE DIARRHOEA, INDIGESTION,NAUSEA AND VOMITING.
Unit Price-
EDL Yes
DescriptionWHITE, OVAL SHAPED FILM COATED TABLETS WITH FLEMING 625 EMBOSSING ON ONE SIDE AND PLAIN ON THE OTHER SIDE
Note
License OwnerBERLIN PHARMA LAO CO.,LTD
ManufacturerMERDREICH LINITED
CountryINDIA
Import Registration No2C 7/56
Import Registration Date21/2/2013
ActivityCERTIFICATE RELEASED
Applied Date2022-08-19
FDD Registration No11 I 3612/11
FDD Registration Date2023-03-31
Expiry Date2026-03-30

Back to drug list